Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
KP-1077 by Zevra Therapeutics for Idiopathic Hypersomnia (IH): Likelihood of Approval
KP-1077 is under clinical development by Zevra Therapeutics and currently in Phase II for Idiopathic Hypersomnia (IH). According to GlobalData,...
KP-1077 by Zevra Therapeutics for Narcolepsy: Likelihood of Approval
KP-1077 is under clinical development by Zevra Therapeutics and currently in Phase II for Narcolepsy. According to GlobalData, Phase II...
Arimoclomol citrate ER by Zevra Therapeutics for Niemann-Pick Disease Type C: Likelihood of Approval
Arimoclomol citrate ER is under clinical development by Zevra Therapeutics and currently in Pre-Registration for Niemann-Pick Disease Type C. According...